Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel × Prednisone × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 20 Lymphoma, Large B-Cell, Diffuse 13 Burkitt Lymphoma 12 Lymphoma, Follicular 9 Lymphoma 9 Lymphoma, Non-Hodgkin 7 Prostatic Neoplasms, Castration-Resistant 5 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, B-Cell, Marginal Zone 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Myasthenia Gravis 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stiff-Person Syndrome 1 Skin Neoplasms 1 Rasmussen subacute encephalitis 1 Prostate Cancer Metastatic 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Ovarian Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡